{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:49:48Z","timestamp":1761860988217,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.mcna.2023.10.003","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T19:29:02Z","timestamp":1698866942000},"page":"403-418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["On The Horizon"],"prefix":"10.1016","volume":"108","author":[{"given":"Chase A.","family":"Cannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie E.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meena S.","family":"Ramchandani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2023.10.003_bib1","unstructured":"Sexually Transmitted Infections National Strategic Plan for the United States: 2021\u20132025 | National Prevention Information Network | Connecting public health professionals with trusted information and each other. https:\/\/npin.cdc.gov\/publication\/sexually-transmitted-infections-national-strategic-plan-united-states-2021%E2%80%932025."},{"issue":"3","key":"10.1016\/j.mcna.2023.10.003_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(17)30725-9","article-title":"Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial","volume":"18","author":"Molina","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"14","key":"10.1016\/j.mcna.2023.10.003_bib3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa2211934","article-title":"Postexposure doxycycline to prevent bacterial sexually transmitted infections","volume":"388","author":"Luetkemeyer","year":"2023","journal-title":"N\u00a0Engl J Med"},{"year":"2023","series-title":"Anrs 174 DOXYVAC: an open-label randomized trial to prevent STIs in MSM on PrEP","author":"Molina","key":"10.1016\/j.mcna.2023.10.003_bib4"},{"year":"2023","series-title":"Doxycycline postexposure prophylaxis for prevention of STIs among cisgender women","author":"Stewart","key":"10.1016\/j.mcna.2023.10.003_bib5"},{"year":"2023","series-title":"Adherence to doxycycline post-exposure prophylaxis for STI prevention among cisgender women","author":"Stewart","key":"10.1016\/j.mcna.2023.10.003_bib6"},{"year":"2022","series-title":"Impact of the daily doxycycline pre-exposure prophylaxis (PrEP) on the incidence of syphilis, gonorrhoea and Chlamydia","key":"10.1016\/j.mcna.2023.10.003_bib7"},{"key":"10.1016\/j.mcna.2023.10.003_bib8","unstructured":"CTN 329: Doxycycline Intervention for bacterial STI ChemoprOphylaxis (DISCO) | Prevention (PREV). CIHR Canadian HIV Trials Network. https:\/\/www.hivnet.ubc.ca\/study\/ctn-329-doxycycline-intervention-for-bacterial-sti-chemoprophylaxis-disco\/."},{"key":"10.1016\/j.mcna.2023.10.003_bib9","unstructured":"CTN 313: The DaDHS Trial | Prevention (PREV). CIHR Canadian HIV Trials Network. https:\/\/www.hivnet.ubc.ca\/study\/ctn-313-the-dadhs-trial\/."},{"key":"10.1016\/j.mcna.2023.10.003_bib10","unstructured":"Mylan Pharmaceuticals, Inc. Doxycycline Package Insert; 2016."},{"key":"10.1016\/j.mcna.2023.10.003_bib11","unstructured":"US Food & Drug Administration. Doxycycline Use by Pregnant and Lactating Women. https:\/\/www.fda.gov\/drugs\/bioterrorism-and-drug-preparedness\/doxycycline-use-pregnant-and-lactating-women."},{"issue":"4","key":"10.1016\/j.mcna.2023.10.003_bib12","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41430-021-00991-6","article-title":"Role of the gut microbiome in chronic diseases: a narrative review","volume":"76","author":"Vijay","year":"2022","journal-title":"Eur J Clin Nutr"},{"year":"2023","series-title":"Resistance-minimizing strategies for introducing a novel antibiotic for gonorrhea treatment: a mathematical modeling study","author":"Reichert","key":"10.1016\/j.mcna.2023.10.003_bib13"},{"key":"10.1016\/j.mcna.2023.10.003_bib14","unstructured":"Public Health - Seattle & King County HIV\/STI\/Hep C Program. Guidelines: Doxycycline Post-Exposure Prophylaxis (Doxy-PEP) to Prevent Bacterial STIs in Men who Have Sex with Men (MSM) and Transgender Persons who Have Sex with Men. Published online June 2023. https:\/\/kingcounty.gov\/depts\/health\/communicable-diseases\/hiv-std.aspx."},{"key":"10.1016\/j.mcna.2023.10.003_bib15","unstructured":"California Department of Public Health. Doxycycline Post-Exposure Prophylaxis (doxy-PEP) for the Prevention of Bacterial Sexually Transmitted Infections (STIs). Published online April 28, 2023. https:\/\/www.cdph.ca.gov\/Programs\/CID\/DCDC\/CDPH%20Document%20Library\/CDPH-Doxy-PEP-Recommendations-for-Prevention-of-STIs.pdf."},{"issue":"6","key":"10.1016\/j.mcna.2023.10.003_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00007435-200106000-00003","article-title":"Self-collection of vaginal swabs for the detection of Chlamydia, gonorrhea, and trichomoniasis: opportunity to encourage sexually transmitted disease testing among adolescents","volume":"28","author":"Wiesenfeld","year":"2001","journal-title":"Sex Transm Dis"},{"issue":"8","key":"10.1016\/j.mcna.2023.10.003_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/OLQ.0b013e3181a44b8c","article-title":"High Performance and Acceptability of Self-Collected Rectal Swabs for Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in Men Who Have Sex With Men and Women","volume":"36","author":"van der Helm","year":"2009","journal-title":"Sex Transm Dis"},{"issue":"7","key":"10.1016\/j.mcna.2023.10.003_bib18","doi-asserted-by":"crossref","first-page":"e0132776","DOI":"10.1371\/journal.pone.0132776","article-title":"Self-Collected versus Clinician-Collected Sampling for Chlamydia and Gonorrhea Screening: A Systemic Review and Meta-Analysis","volume":"10","author":"Lunny","year":"2015","journal-title":"PLoS One"},{"year":"2021","series-title":"Screening for Chlamydial and Gonococcal Infections: A Systematic Review Update for the U.S. Preventive Services Task Force [Internet]","author":"Cantor","key":"10.1016\/j.mcna.2023.10.003_bib19"},{"issue":"3","key":"10.1016\/j.mcna.2023.10.003_bib20","first-page":"296","article-title":"Acceptability of self-collecting oropharyngeal swabs for sexually transmissible infection testing among men and women","volume":"16","author":"Dangerfield","year":"2019","journal-title":"Sex Health"},{"issue":"2","key":"10.1016\/j.mcna.2023.10.003_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.idc.2023.02.002","article-title":"Advances in Diagnostics of Sexually Transmitted Infections","volume":"37","author":"Kahn","year":"2023","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.mcna.2023.10.003_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1128\/JCM.02966-13","article-title":"Detection of Trichomonas vaginalis DNA by Use of Self-Obtained Vaginal Swabs with the BD ProbeTec Q x Assay on the BD Viper System","volume":"52","author":"Van Der Pol","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.mcna.2023.10.003_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001349","article-title":"Self-collection of samples as an additional approach to deliver testing services for sexually transmitted infections: a systematic review and meta-analysis","volume":"4","author":"Ogale","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.mcna.2023.10.003_bib24","unstructured":"Aptima Combo 2 Assay for CT\/NG Package Insert | Hologic."},{"issue":"2","key":"10.1016\/j.mcna.2023.10.003_bib25","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/QAI.0000000000000979","article-title":"Implementation and Operational Research: Effectiveness and Patient Acceptability of a Sexually Transmitted Infection Self-Testing Program in an HIV Care Setting","volume":"72","author":"Barbee","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr 1999"},{"issue":"9","key":"10.1016\/j.mcna.2023.10.003_bib26","first-page":"CD011317","article-title":"Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections","volume":"2015","author":"Fajardo-Bernal","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mcna.2023.10.003_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/OLQ.0000000000000785","article-title":"Let\u2019s Take A \u201cSelfie\u201d: Self-Collected Samples for Sexually Transmitted Infections","volume":"45","author":"Gaydos","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.mcna.2023.10.003_bib28","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/JCM.03461-12","article-title":"Performance of the Cepheid CT\/NG Xpert Rapid PCR Test for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae","volume":"51","author":"Gaydos","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"11","key":"10.1016\/j.mcna.2023.10.003_bib29","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.5858\/arpa.2020-0118-RA","article-title":"Point-of-Care Testing for Sexually Transmitted Infections: A Review of Recent Developments","volume":"144","author":"Adamson","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"8S","key":"10.1016\/j.mcna.2023.10.003_bib30","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1097\/OLQ.0000000000001457","article-title":"A\u00a0Narrative Review of Where We Are With Point-of-Care Sexually Transmitted Infection Testing in the United States","volume":"48","author":"Gaydos","year":"2021","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.mcna.2023.10.003_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.annemergmed.2018.09.012","article-title":"Use of a Rapid Diagnostic for Chlamydia trachomatis and Neisseria gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management: Report of a Randomized Clinical Trial","volume":"74","author":"Gaydos","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.mcna.2023.10.003_bib32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/OLQ.0000000000000438","article-title":"A\u00a0Randomized Controlled Trial Comparing the Treatment of Patients Tested for Chlamydia and Gonorrhea After a Rapid Polymerase Chain Reaction Test Versus Standard of Care Testing","volume":"43","author":"May","year":"2016","journal-title":"Sex Transm Dis"},{"issue":"6","key":"10.1016\/j.mcna.2023.10.003_bib33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/sextrans-2014-051580","article-title":"Diagnostics within the clinic to test for gonorrhoea and chlamydia reduces the time to treatment: a service evaluation","volume":"90","author":"Wingrove","year":"2014","journal-title":"Sex Transm Infect"},{"issue":"11","key":"10.1016\/j.mcna.2023.10.003_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/OLQ.0000000000001056","article-title":"Sexually Transmitted Infection Positivity Among Adolescents With or at High-Risk for Human Immunodeficiency Virus Infection in Los Angeles and New Orleans","volume":"46","author":"Shannon","year":"2019","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.mcna.2023.10.003_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/OLQ.0000000000001088","article-title":"Safety and Effectiveness of Same-Day Chlamydia trachomatis and Neisseria gonorrhoeae Screening and Treatment Among Gay, Bisexual, Transgender, and Homeless Youth in Los Angeles, California, and New Orleans, Louisiana","volume":"47","author":"Keizur","year":"2020","journal-title":"Sex Transm Dis"},{"year":"2023","series-title":"Sexually transmitted disease surveillance 2021","key":"10.1016\/j.mcna.2023.10.003_bib36"},{"issue":"S4","key":"10.1016\/j.mcna.2023.10.003_bib37","first-page":"S3","article-title":"A\u00a0systematic review and meta-analysis of studies evaluating the performance and operational characteristics of dual point-of-care tests for HIV and syphilis","volume":"93","author":"Gliddon","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"13","key":"10.1016\/j.mcna.2023.10.003_bib38","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.3390\/ijerph19138172","article-title":"Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward","volume":"19","author":"Pham","year":"2022","journal-title":"Int J Environ Res Publ Health"},{"issue":"S4","key":"10.1016\/j.mcna.2023.10.003_bib39","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1136\/sextrans-2016-053072","article-title":"Rapid accurate point-of-care tests combining diagnostics and antimicrobial resistance prediction for Neisseria gonorrhoeae and Mycoplasma genitalium","volume":"93","author":"Sadiq","year":"2017","journal-title":"Sex Transm Infect"},{"issue":"593","key":"10.1016\/j.mcna.2023.10.003_bib40","doi-asserted-by":"crossref","first-page":"eabf6356","DOI":"10.1126\/scitranslmed.abf6356","article-title":"A\u00a0portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility","volume":"13","author":"Trick","year":"2021","journal-title":"Sci Transl Med"},{"issue":"36","key":"10.1016\/j.mcna.2023.10.003_bib41","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1016\/j.vaccine.2015.07.015","article-title":"The potential impact of vaccination on the prevalence of gonorrhea","volume":"33","author":"Craig","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.mcna.2023.10.003_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fimmu.2019.00683","article-title":"Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines","volume":"10","author":"Petousis-Harris","year":"2019","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.mcna.2023.10.003_bib43","doi-asserted-by":"crossref","first-page":"e1008602","DOI":"10.1371\/journal.ppat.1008602","article-title":"The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae","volume":"16","author":"Leduc","year":"2020","journal-title":"PLoS Pathog"},{"issue":"7","key":"10.1016\/j.mcna.2023.10.003_bib44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cid\/ciy1061","article-title":"The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"6","key":"10.1016\/j.mcna.2023.10.003_bib45","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3201\/eid2206.151093","article-title":"Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway","volume":"22","author":"Whelan","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.mcna.2023.10.003_bib46","doi-asserted-by":"crossref","first-page":"e1341","DOI":"10.1093\/cid\/ciac436","article-title":"Prevention of Neisseria gonorrhoeae With Meningococcal B Vaccine: A Matched Cohort Study in Southern California","volume":"76","author":"Bruxvoort","year":"2023","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"year":"2023","series-title":"Meningitis B vaccine for prevention of gonorrhoea: what is the evidence?","author":"Molina","key":"10.1016\/j.mcna.2023.10.003_bib47"},{"issue":"1","key":"10.1016\/j.mcna.2023.10.003_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1186\/s12889-023-15516-y","article-title":"An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol","volume":"23","author":"Thng","year":"2023","journal-title":"BMC Publ Health"},{"issue":"9","key":"10.1016\/j.mcna.2023.10.003_bib49","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/d41591-023-00069-9","article-title":"GSK\u2019s gonorrhea vaccine receives fast-track designation to expedite clinical trials","volume":"29","author":"Johnson","year":"2023","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.mcna.2023.10.003_bib50","first-page":"1206","article-title":"Immunity in experimental syphilis. VI. Successful vaccination of rabbits with Treponema pallidum, Nichols strain, attenuated by -irradiation","volume":"110","author":"Miller","year":"1973","journal-title":"J\u00a0Immunol Baltim Md 1950"},{"key":"10.1016\/j.mcna.2023.10.003_bib51","doi-asserted-by":"crossref","first-page":"1126170","DOI":"10.3389\/fimmu.2023.1126170","article-title":"Syphilis vaccine: challenges, controversies and opportunities","volume":"14","author":"\u00c1vila-Nieto","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.mcna.2023.10.003_bib52","doi-asserted-by":"crossref","first-page":"103281","DOI":"10.1016\/j.ebiom.2021.103281","article-title":"Efficacy of linezolid on Treponema pallidum, the syphilis agent: A preclinical study","volume":"65","author":"Haynes","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.mcna.2023.10.003_bib53","doi-asserted-by":"crossref","first-page":"e1218","DOI":"10.1128\/mBio.01153-18","article-title":"Long-Term In\u00a0Vitro Culture of the Syphilis Spirochete Treponema pallidum subsp. pallidum","volume":"9","author":"Edmondson","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.mcna.2023.10.003_bib54","doi-asserted-by":"crossref","first-page":"1007056","DOI":"10.3389\/fmicb.2022.1007056","article-title":"High-throughput nanopore sequencing of Treponema pallidum tandem repeat genes arp and tp0470 reveals clade-specific patterns and recapitulates global whole genome phylogeny","volume":"13","author":"Lieberman","year":"2022","journal-title":"Front Microbiol"},{"issue":"52","key":"10.1016\/j.mcna.2023.10.003_bib55","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1016\/j.vaccine.2022.11.002","article-title":"Immunization with a tri-antigen syphilis vaccine significantly attenuates chancre development, reduces bacterial load, and inhibits dissemination of Treponema pallidum","volume":"40","author":"Lukehart","year":"2022","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.mcna.2023.10.003_bib56","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","volume":"19","author":"Abraham","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.mcna.2023.10.003_bib57","first-page":"CD013479","article-title":"Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males","volume":"2019","author":"Bergman","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.mcna.2023.10.003_bib58","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/jama.2019.18411","article-title":"Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"323","author":"Oshman","year":"2020","journal-title":"JAMA"},{"issue":"41","key":"10.1016\/j.mcna.2023.10.003_bib59","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1016\/j.vaccine.2022.08.020","article-title":"Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021-March 2022","volume":"40","author":"Prudden","year":"2022","journal-title":"Vaccine"},{"year":"2022","series-title":"Strategic advisory group of experts on immunization","author":"World Health Organization","key":"10.1016\/j.mcna.2023.10.003_bib60"},{"year":"2022","series-title":"Human papillomavirus vaccines","author":"World Health Organization","key":"10.1016\/j.mcna.2023.10.003_bib61"},{"issue":"1","key":"10.1016\/j.mcna.2023.10.003_bib62","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vaccine.2021.11.041","article-title":"Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial","volume":"40","author":"Porras","year":"2022","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.mcna.2023.10.003_bib63","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/OLQ.0000000000000832","article-title":"Acceptability and Feasibility of Rapid Chlamydial, Gonococcal, and Trichomonal Screening and Treatment in Pregnant Women in 6 Low- to Middle-Income Countries","volume":"45","author":"Shannon","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"11","key":"10.1016\/j.mcna.2023.10.003_bib64","doi-asserted-by":"crossref","first-page":"e0259593","DOI":"10.1371\/journal.pone.0259593","article-title":"Molecular chlamydia and gonorrhoea point of care tests implemented into routine practice: Systematic review and value proposition development","volume":"16","author":"Fuller","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mcna.2023.10.003_bib65","doi-asserted-by":"crossref","first-page":"e204819","DOI":"10.1001\/jamanetworkopen.2020.4819","article-title":"Evaluation of the Performance of a Point-of-Care Test for Chlamydia and Gonorrhea","volume":"3","author":"Van Der Pol","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.mcna.2023.10.003_bib66","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/OLQ.0000000000000865","article-title":"Performance of the Atlas Genetics Rapid Test for Chlamydia trachomatis and Women\u2019s Attitudes Toward Point-Of-Care Testing","volume":"45","author":"Widdice","year":"2018","journal-title":"Sex Transm Dis"},{"issue":"9","key":"10.1016\/j.mcna.2023.10.003_bib67","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/14737159.2021.1952074","article-title":"A\u00a0profile of the binx health io\u00ae molecular point-of-care test for chlamydia and gonorrhea in women and men","volume":"21","author":"Van Der Pol","year":"2021","journal-title":"Expert Rev Mol Diagn"},{"issue":"5","key":"10.1016\/j.mcna.2023.10.003_bib68","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1473-3099(20)30734-9","article-title":"Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study","volume":"21","author":"Morris","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.mcna.2023.10.003_bib69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/OLQ.0000000000001586","article-title":"Clinical Integration of a Highly Accurate Polymerase Chain Reaction Point-of-Care Test Can Inform Immediate Treatment Decisions for Chlamydia, Gonorrhea, and Trichomonas","volume":"49","author":"Dawkins","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"2","key":"10.1016\/j.mcna.2023.10.003_bib70","doi-asserted-by":"crossref","first-page":"e1117","DOI":"10.1128\/JCM.01091-17","article-title":"Clinical Evaluation of the Cepheid Xpert TV Assay for Detection of Trichomonas vaginalis with Prospectively Collected Specimens from Men and Women","volume":"56","author":"Schwebke","year":"2018","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.mcna.2023.10.003_bib71","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/14737159.2017.1282823","article-title":"Clinical performance of the Solana\u00ae Point-of-Care Trichomonas Assay from clinician-collected vaginal swabs and urine specimens from symptomatic and asymptomatic women","volume":"17","author":"Gaydos","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"issue":"S4","key":"10.1016\/j.mcna.2023.10.003_bib72","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1136\/sextrans-2016-053063","article-title":"Rapid and point-of-care tests for the diagnosis of Trichomonas vaginalis in women and men","volume":"93","author":"Gaydos","year":"2017","journal-title":"Sex Transm Infect"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712523001566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712523001566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:48:00Z","timestamp":1758419280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712523001566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0025712523001566"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2023.10.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"type":"print","value":"0025-7125"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On The Horizon","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2023.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}